COVID-19 is Driving a Silent Health Crisis as it Rapidly Causes a Unique Form of Lethal Atherosclerosis in Many!

Medical News: A Hidden Threat
COVID-19 has long been associated with respiratory complications, but recent research has unveiled an alarming connection between the virus and cardiovascular health. Scientists from Fudan University in Shanghai, China, have discovered that SARS-CoV-2 infection can accelerate the development of a unique and dangerous form of atherosclerosis, a condition where arteries become narrowed and hardened due to plaque buildup. This revelation has profound implications for the long-term health of millions worldwide, as the consequences of this phenomenon could lead to increased cases of heart attacks and heart failure in the future.


COVID-19 is Driving a Silent Health Crisis as it Rapidly Causes a Unique Form of Lethal Atherosclerosis in Many

While it has been known that COVID-19 can cause severe inflammation and blood clotting, this Medical News report highlights how the virus directly impacts the arteries supplying blood to the heart. The study’s findings suggest that even mild cases of COVID-19 may lead to accelerated plaque progression in the coronary arteries, increasing the risk of life-threatening cardiovascular events. Researchers warn that this could translate into a significant public health crisis in the coming years.
 
Understanding the Study: The Impact of COVID-19 on the Arteries
To explore the relationship between COVID-19 and atherosclerosis, the research team led by Dr. Junbo Ge at Zhongshan Hospital in Shanghai conducted an in-depth analysis using advanced coronary CT angiography (CCTA) imaging. They examined 803 patients who underwent at least two CCTA scans before and during the pandemic. Out of these, 690 patients had contracted COVID-19 at some point between their first and final scans, while the remaining 113 had not been infected.
 
The study focused on tracking the changes in plaque volume, identifying high-risk plaque characteristics, and assessing coronary inflammation in these individuals.
 
The results were striking: those who had COVID-19 exhibited a much faster rate of plaque growth in their arteries compared to those who were never infected. More concerningly, the plaques in COVID-19 patients were more likely to develop into high-risk plaques, which are prone to rupture and cause heart attacks or strokes.
 
Key Findings: COVID-19’s Role in a Unique Form of Atherosclerosis
The research uncovered several alarming trends:
 
-Accelerated Plaque Growth: Patients who had COVID-19 experienced a 20.1% increase in plaque volume, compared to 15.8% in non-infected individuals.
 
-Reduction in Plaque Calcification: Normally, as plaques develop, some become calcified, which stabilizes them. However, in COVID-19 patients, there was a decrease in plaque calcification, making plaques more unstable and more likely to rupture.
 
-Higher Incidence of Inflammation: Arterial inflammation was significantly higher in COVID-19 patients, a key factor that contributes to plaque instability.
 
-Increased Risk of Target Lesion Failure: The risk of a serious cardiovascular event such as a heart attack was nearly three times higher (10.4% vs. 3.1%) in individuals who had COVID-19.
 
-Hyperinflammatory Response: COVID-19 was associated with a persistent inflammatory state in the arteries, even after recovery from the initial infection.
 
These findings indicate that SARS-CoV-2 infection doesn’t just exacerbate existing cardiovascular conditions - it actively promotes the development of a unique and more dangerous form of atherosclerosis, increasing the likelihood of severe heart-related complications.
 
What Makes This Type of Atherosclerosis Unique?
While atherosclerosis is a common cardiovascular disease, the version seen in COVID-19 patients appears to have distinct characteristics:
 
-Rapid Plaque Progression: The growth rate of plaques in COVID-19 patients was significantly faster than what is typically seen in individuals without the virus.
 
-Noncalcified Plaque Dominance: Atherosclerosis normally involves a mix of calcified and noncalcified plaques, but in COVID-19 patients, there was an increase in noncalcified plaques, which are more likely to rupture and cause sudden heart attacks.
 
-Ongoing Inflammatory Effects: COVID-19 appears to trigger a long-lasting hyperinflammatory state, which continues to affect arterial health months after infection.
 
-Higher Risk of Cardiovascular Events: Compared to the general population, individuals with prior SARS-CoV-2 infections were significantly more likely to experience serious heart-related events, even in cases where the initial infection was mild.
 
Public Health Concerns and the Future Impact
Experts from King’s College London and the Liverpool Centre for Cardiovascular Science, UK, have raised concerns that these findings could signal a widespread cardiovascular crisis in the coming years. With more than 800 million confirmed COVID-19 cases globally, even a small increase in plaque progression and cardiovascular complications could translate into millions of additional heart attacks and strokes.
 
One of the key takeaways from this research is that even mild cases of COVID-19 appear to contribute to cardiovascular disease progression. This challenges the assumption that only severe infections have long-term health effects and underscores the need for proactive cardiovascular monitoring in individuals who have had COVID-19.
 
What Can Be Done? Potential Prevention and Treatment Strategies
With these findings in mind, researchers and healthcare professionals are calling for urgent action to integrate COVID-19 into cardiovascular care protocols.
 
Possible strategies include:
Increased Heart Health Screenings: Individuals who have recovered from COVID-19, especially those with existing risk factors, should undergo regular cardiovascular check-ups.
 
-Use of Anti-Inflammatory Medications: Given the link between inflammation and plaque instability, anti-inflammatory treatments could play a role in reducing cardiovascular risks.
 
-Statin Therapy: Cholesterol-lowering drugs like statins may help slow plaque progression in COVID-19-affected patients.
 
-Further Research on COVID-19’s Long-Term Impact: Larger, multi-center studies are needed to confirm these findings and determine effective treatment strategies.
 
The Urgent Need for Prospective Studies
While this study provides groundbreaking insights, researchers emphasize that more prospective studies are needed to validate the long-term impact of COVID-19 on cardiovascular health. Understanding how and why the virus accelerates atherosclerosis will be crucial in developing targeted treatments and mitigating future risks.
 
In conclusion, the study’s findings underscore a hidden but growing health crisis: COVID-19 is not just a respiratory disease - it has far-reaching consequences on cardiovascular health. By promoting the growth of high-risk, unstable plaques in the arteries, the virus is quietly increasing the risk of heart attacks and strokes in millions of people. As the world continues to navigate the pandemic’s aftermath, addressing this cardiovascular risk will be critical in preventing future health crises.
 
The study findings were published in the peer-reviewed journal: Radiology.
https://pubs.rsna.org/doi/10.1148/radiol.240876
 
For the latest COVID-19 News, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/american-study-warns-that-covid-19-is-triggering-the-onset-and-progression-of-atherosclerosis-in-many
 
https://www.thailandmedical.news/news/geniposide-a-promising-treatment-for-covid-19-and-atherosclerosis-patients
 
https://www.thailandmedical.news/news/covid-19-causes-dyslipidemia-in-those-with-diabetes-increasing-risk-for-atherosclerotic-complications
 
https://www.thailandmedical.news/news/is-platelet-activating-factor-the-key-link-between-covid-19-and-atherosclerosis-risk
 
https://www.thailandmedical.news/news/herbs-and-phytochemicals-corilagin-from-hypophyllum-eliminates-macrophages-inflammation-in-atherosclerosis-through-tlr4-nf%CE%BAb-mapk-pathway
 
https://www.thailandmedical.news/news/breaking-news-new-york-study-finds-that-sars-cov-2-infection-triggers-pro-atherogenic-inflammatory-1-responses-in-human-coronary-vessels